These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1819005)

  • 21. Left ventricular hypertrophy: beyond the image and defining the human cardiac phenotype in hypertension.
    Jennings GL; McMullen JR
    J Hypertens; 2007 May; 25(5):941-7. PubMed ID: 17414655
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG; Leenen FH; Tanner J
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive and humoral effects of verapamil and lacidipine in combination in hypertensive patients.
    Comerio G; Cuspidi C; Bocciolone M; Lonati L; Sampieri L; Boselli L; Leonetti G; Zanchetti A
    J Hypertens Suppl; 1993 Dec; 11(5):S336-7. PubMed ID: 8158411
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of effects of nitrendipine versus hydrochlorothiazide on left ventricular structure and function and neurohumoral status in systemic hypertension.
    Giles TD; Sander GE; Roffidal LE; Mazzu A
    Am J Cardiol; 1990 May; 65(18):1265-8. PubMed ID: 2186606
    [No Abstract]   [Full Text] [Related]  

  • 27. Time course of cardiac performance in hypertensive patients after verapamil assessed by nuclear ventriculography.
    González-Gómez A; Fránquiz J; García-Barreto D
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):292-7. PubMed ID: 2387652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular mass and cardiac function in patients with essential hypertension.
    Grossman E; Oren S; Messerli FH
    J Hum Hypertens; 1994 Jun; 8(6):417-21. PubMed ID: 8089826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Action of verapamil in a single oral dose in arterial hypertension. Evaluation by echocardiography and phonomechanocardiography].
    Ortiz J; Barreto AC; Savioli RM; Barbato AJ; Netto MP; Monaco CA; Del Nero Júnior E; Tranchesi J; Pileggi F
    Arq Bras Cardiol; 1979 Jan; 32(1):63-70. PubMed ID: 464849
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute hypotensive effect after sublingual verapamil].
    Chen YS; Li JL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Feb; 17(1):35-6. PubMed ID: 2766944
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of nimodipine on blood pressure and cardiac function in hypertensive patients].
    Wang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 1989 Dec; 17(6):341-3. PubMed ID: 2637128
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ultrasonic study of cardiac anatomy and function in essential hypertension (author's transl)].
    Zhang CD
    Zhonghua Nei Ke Za Zhi; 1981 Nov; 20(11):646-9. PubMed ID: 6210512
    [No Abstract]   [Full Text] [Related]  

  • 33. Stroke volume and left heart anatomy in relation to plasma volume in essential hypertension.
    Ganau A; Arru A; Saba PS; Piga G; Glorioso N; Tonolo G; Madeddu G; Bianchi G
    J Hypertens Suppl; 1991 Dec; 9(6):S150-1. PubMed ID: 1818920
    [No Abstract]   [Full Text] [Related]  

  • 34. Verapamil, low-sodium regimens, and blood pressure.
    Beard TC; Cooke HM; Gray WR; Wild P
    Lancet; 1986 Nov; 2(8516):1164-5. PubMed ID: 2877315
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathophysiology and clinical implications of early structural changes.
    Hypertension; 1984; 6(6 Pt 2):III1-187. PubMed ID: 6519749
    [No Abstract]   [Full Text] [Related]  

  • 36. Verapamil in stuttering.
    Brady JP; McAllister TW; Price TR
    Biol Psychiatry; 1990 Mar; 27(6):680-1. PubMed ID: 2182135
    [No Abstract]   [Full Text] [Related]  

  • 37. The heart in hypertension.
    Dickinson CJ
    Lancet; 1968 May; 1(7551):1088. PubMed ID: 4171764
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of acute and chronic administration of verapamil on cardiac structure and function in essential hypertension without left ventricular hypertrophy.
    Cuspidi C; Sampieri L; Boselli L; Bragato R; Lonati L; Bocciolone M; Leonetti G; Zanchetti A
    J Hypertens Suppl; 1991 Dec; 9(6):S402-3. PubMed ID: 1819005
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of hypertension with a delayed-action form of verapamil and its effect on hypertrophy and function of the left ventricle].
    Spacek R; Kozák P; Stárek A; Hes I; Skalníková V
    Vnitr Lek; 1987 Nov; 33(11):953-61. PubMed ID: 2964119
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of bisoprolol and verapamil in hypertension: influence on left ventricular mass and function--a pilot study.
    Gosse P; Gressin V; Clerson P; Lemetayer P; Clémenty J
    Therapie; 1999; 54(2):217-22. PubMed ID: 10394257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.